AI to Revolutionize Biopharmaceutical Manufacturing, Says Northeastern ProfessorMarch 4, 2025 A Northeastern University professor is developing an AI-driven methodology to improve the creation of life-saving biopharmaceuticals.
Corporation BioVaxys Receives Management Cease Trade Order from British Columbia Securities CommissionMarch 4, 2025 BioVaxys Technology Corp. has received a management cease trade order (MCTO) from the British Columbia Securities Commission due to delays in filing its audited annual financial statements.
